Evidence-based·Last reviewed May 30, 2026·How we grade evidence

Oregon Grape

BotanicalRoot extract

Useful mainly for people with mild plaque psoriasis seeking a topical option.

Quick decision guide

May help most

people with mild plaque psoriasis seeking a topical option

Common dosing range

10% cream topically twice daily; 500–3000 mg/day dried root orally

When to expect effects

Weeks (topical psoriasis)

Watch out for

berberine content inhibits CYP3A4/2D6 and P-glycoprotein, raising levels of many drugs; avoid in pregnancy and infants

What is it

Oregon grape ( Mahonia aquifolium , also classified as Berberis aquifolium ) is an evergreen shrub native to the Pacific Northwest of North America whose yellow inner bark and root have a long ethnobotanical history of use by Indigenous peoples and in Western herbalism. The plant is rich in isoquinoline alkaloids - principally berberine, berbamine, and oxyacanthine - which are responsible for its characteristic bitter taste, yellow colour, and most of its pharmacological activity. Modern supplement use centres on standardised root and bark extracts, often quantified by berberine content, marketed for digestive, skin, and antimicrobial support.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if

You have mild plaque psoriasis and want to trial a 10% topical cream
You are not pregnant, breastfeeding, or dosing an infant
You can separate oral use from interacting medications

Probably skip if

You are pregnant or breastfeeding (kernicterus risk in neonates)
You take cyclosporine, statins, or macrolide antibiotics without separation
You expect proven systemic antimicrobial or digestive benefit

Evidence at a glance

plaque psoriasis (topical)

Limited Evidence
Effect
Modest improvement in plaque severity
Best fit
adults with mild-to-moderate plaque psoriasis
Time
Weeks

glycemic and lipid effects (via berberine)

Limited Evidence
Effect
Modest reductions in glucose and lipids
Best fit
adults with elevated glucose or lipids using berberine-standardized extracts
Time
Weeks

antimicrobial and antifungal effects

Mixed Evidence
Effect
Unclear in humans
Best fit
not established
Time
Unclear

Evidence for 3 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

plaque psoriasis (topical)

Disease adjunct
Limited Evidence

A small clinical evidence base supports 10% Mahonia aquifolium cream for reducing plaque severity in mild-to-moderate psoriasis. Effects are modest and studies are limited in size and quality.

Effect size
Modest improvement in plaque severity
Time to effect
Weeks
Best fit
adults with mild-to-moderate plaque psoriasis
Less likely
severe or extensive psoriasis

Bottom line: Topical 10% cream may modestly improve mild plaque psoriasis.

glycemic and lipid effects (via berberine)

Biomarker support
Limited Evidence

Oregon grape's main alkaloid, berberine, lowers fasting glucose, HbA1c, and LDL in meta-analyses of berberine trials. This evidence is for purified berberine, not Oregon grape extract specifically, and reflects biomarker changes rather than tested clinical outcomes.

Effect size
Modest reductions in glucose and lipids
Time to effect
Weeks
Best fit
adults with elevated glucose or lipids using berberine-standardized extracts

Bottom line: Berberine content may shift glucose and lipid markers, but this is extrapolated from purified berberine, not Oregon grape itself.

antimicrobial and antifungal effects

Mechanism only
Mixed Evidence

Berberine-containing extracts show antibacterial and antifungal activity in laboratory studies. There is little controlled human evidence that oral or topical Oregon grape treats clinical infections.

Effect size
Unclear in humans
Time to effect
Unclear
Best fit
not established

Bottom line: Antimicrobial activity is shown in the lab but not demonstrated clinically.

How to take it

1. Typical dose
Topical: 10% Mahonia aquifolium cream twice daily. Oral: 500–3000 mg/day dried root, or extract delivering 200–500 mg berberine-equivalent alkaloids
2. Timing
topical applied to affected skin; oral split through the day
3. With food
oral with food to reduce GI upset
4. How long to try
Topical: trial several weeks. Oral systemic use generally limited to a few weeks

What to track

psoriasis plaque severity and itch
skin irritation from the cream
digestive symptoms
blood glucose if diabetic

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

GI upsetnauseabitter aftertasteskin irritation with topical use

Serious risks

  • kernicterus risk in neonates from berberine displacing bilirubin

Who should avoid it

  • pregnancy and breastfeeding
  • infants
  • people requiring narrow-therapeutic-index drugs metabolized by CYP3A4/2D6

Pregnancy & breastfeeding

Contraindicated in pregnancy and lactation; berberine crosses the placenta and can raise neonatal kernicterus risk.

Interactions

cyclosporineMajor

berberine inhibits CYP3A4 and P-glycoprotein, raising cyclosporine levels

statins and macrolide antibioticsModerate

CYP3A4/P-gp inhibition can raise plasma drug levels; separate dosing

antidiabetic drugsModerate

additive glucose-lowering effect

antihypertensivesMinor

possible additive blood-pressure lowering

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for

standardized to berberine-equivalent alkaloids
names Mahonia/Berberis aquifolium and plant part
10% strength for topical psoriasis creams

Be skeptical of

'natural antibiotic'
broad 'detox' or infection-cure claims
use in pregnancy or infants

References by claim

plaque psoriasis (topical)

Augustin et al., 1999PubMed (1999) link

Bernstein et al., 2006PubMed (2006) link

glycemic and lipid effects (via berberine)

Liang et al., 2019PubMed (2019) link

Hernandez et al., 2024PubMed (2024) link

antimicrobial and antifungal effects

Slobodníková et al., 2004PubMed (2004) link

Rohrer et al., 2007PubMed (2007) link

Track Oregon Grape with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.